Skip to main content

Closed

VKTX: Viking Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

43thpctl

Volume

0.79×avg

Market Cap

3.70BUSD

P/E Ratio

-6.8TTM

Div Yield

-ann

Viking Therapeutics, Inc.

VKTXNASDAQ Capital Market·USD·Closed

Viking Therapeutics, Inc.

VKTXNASDAQ·USD·Closed

$31.74

−4.14%

$31.74

−$1.37 (4.14%)

52W Range

43thpctl

Volume

0.79×avg

Mkt Cap

3.70BUSD

P/E

-6.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings